GO Term ID; Description; Percent of Genes in Sample; Percent of Genes in Background; P-value;Genes;Web Address 
GO:0006996; organelle organization and biogenesis; 141 of 300 (47%); 308 of 1139 (27.0%); 0.000e+00; SWC3, DEP1, GPB2, ECM1, NUP60, SWD1, SLA1, HIR1, HHF1, CCZ1, YBR238C, DPB3, DCC1, BIK1, MGR1, MRC1, SNT1, HCM1, CSM1, SCS2, BEM2, RPL8A, RRM3, SRB2, ARP1, THP2, CTF8, SEC28, SDS3, ICE2, RAD27, VPS51, UTH1, NAP1, DYN1, NUP133, BST1, PTC1, RPN4, BRE1, VAM6, ASM4, ARF1, RAD57, PAA1, VPS41, RRP8, ARX1, GSG1, NUM1, RPA14, NUP42, RAV2, UME6, HTA1, SWR1, ESC2, XRS2, SPT3, VPS72, GET1, SGF73, HUR1, KEM1, HOS2, VAM7, KIP3, RTF1, RTG2, UPF3, SLX9, PHB1, CHO2, SMI1, YTA7, SYS1, MAD2, ASF1, PBS2, RPA34, SET2, POL32, HIR3, ENT4, BRE2, RAD5, ARP6, MMR1, UPS1, MMS22, VAC14, CDC73, RAD52, SRC1, VPS9, NUP188, TUB3, CSM3, CTF18, POM152, SGS1, CIK1, MRE11, SAP30, ZDS1, DYN3, PHO23, EAF7, CSE2, SSK2, SIN3, TOP1, RTS1, HST3, SHE4, WHI2, ASE1, VAM10, LEO1, RGA1, ELG1, SLK19, PNT1, PAC1, CHL1, IRC15, LGE1, ELP3, MGR2, NIP100, CTI6, LEA1, NEW1, CIN2, VIK1, RLF2, EAF3, MED1, KAR3, HDA3, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0006996; 
GO:0016043; cellular component organization and biogenesis; 198 of 300 (66%); 461 of 1139 (40.5%); 0.000e+00; VPS8, SWC3, DEP1, GPB2, ECM1, NUP60, SWD1, SLA1, HIR1, EDE1, SKT5, SFT2, HHF1, ECM33, CCZ1, ARL1, SEC66, BEM1, YBR238C, DPB3, APM3, DCC1, BIK1, MGR1, MRC1, SNT1, THR4, HCM1, CSM1, GET2, SCS2, BEM2, RPL8A, VPS29, SLT2, RRM3, SRB2, GGA2, ARP1, CHS7, THP2, CTF8, APQ12, SEC28, SDS3, ICE2, IST3, ELM1, HSL1, RAD27, LST4, VPS51, UTH1, NAP1, DYN1, NUP133, MLP1, BST1, BUD27, PTC1, RPN4, BRE1, VAM6, ASM4, GET3, ARF1, RAD57, PAA1, VPS41, RRP8, ARX1, GSG1, NUM1, ENT5, RPA14, NUP42, RAV2, UME6, HTA1, SSD1, SWR1, MSN5, ESC2, XRS2, SPT3, ERD1, VPS72, COG7, GET1, CWH41, ERV14, SGF73, MAD1, HUR1, KEM1, HOS2, VAM7, KIP3, RTF1, RTG2, UPF3, SLX9, PHB1, CHO2, KRE11, SMI1, YTA7, SYS1, MAD2, BCK1, CHS6, ASF1, PBS2, RPA34, VPS35, SET2, POL32, HOC1, HIR3, ENT4, VPS13, BRE2, POM34, RAD5, ARP6, AVL9, MMR1, UPS1, YPT6, SEC72, MMS22, CHS5, MID2, FKS1, VAC14, CDC73, RAD52, SRC1, COG8, VPS9, NUP188, TUB3, MVP1, CSM3, CTF18, POM152, SGS1, CIK1, MRE11, SAP30, ZDS1, JNM1, DYN3, GAS1, COG6, COG5, PHO23, EAF7, VPS27, CSE2, SSK2, SIN3, TOP1, TLG2, RTS1, HST3, SHE4, CKB2, WHI2, ASE1, VAM10, VAM3, LEO1, RGA1, VPS17, ELG1, SLK19, RUD3, PNT1, PAC1, CHL1, IRC15, ARL3, LGE1, ELP3, MGR2, NIP100, CTI6, LEA1, NEW1, CIN2, VIK1, RLF2, EAF3, MED1, KAR3, HDA3, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0016043; 
GO:0051276; chromosome organization and biogenesis; 94 of 300 (31%); 162 of 1139 (14.2%); 0.000e+00; SWC3, DEP1, GPB2, NUP60, SWD1, HIR1, HHF1, DPB3, DCC1, MRC1, SNT1, HCM1, CSM1, SCS2, SRB2, THP2, CTF8, SDS3, RAD27, UTH1, NAP1, DYN1, PTC1, RPN4, BRE1, VAM6, ARF1, RAD57, PAA1, RRP8, RPA14, UME6, HTA1, SWR1, ESC2, XRS2, SPT3, VPS72, SGF73, HUR1, KEM1, HOS2, VAM7, RTF1, RTG2, UPF3, CHO2, SMI1, YTA7, MAD2, ASF1, SET2, POL32, HIR3, BRE2, RAD5, ARP6, MMS22, CDC73, RAD52, SRC1, VPS9, TUB3, CSM3, CTF18, SGS1, CIK1, MRE11, SAP30, ZDS1, PHO23, EAF7, CSE2, SIN3, TOP1, RTS1, HST3, WHI2, LEO1, ELG1, CHL1, IRC15, LGE1, ELP3, CTI6, LEA1, NEW1, VIK1, RLF2, EAF3, MED1, KAR3, HDA3, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0051276; 
GO:0009987; cellular process; 289 of 300 (96%); 954 of 1139 (83.8%); 9.018e-12; VPS8, SWC3, DEP1, GPB2, CNE1, ECM1, NUP60, SWD1, SLA1, HIR1, ACH1, EDE1, SKT5, SFT2, HHF1, ECM33, UBC4, MMS4, CCZ1, ARL1, SEC66, BEM1, YBR238C, RGD1, DPB3, APM3, DCC1, BIK1, MGR1, MRC1, SNT1, THR4, HCM1, PAT1, CSM1, GET2, SWI4, SCS2, UBP3, BEM2, RPL8A, VPS29, SLT2, RRM3, SRB2, GGA2, UBA4, ARP1, CHS7, RTT107, THP2, PTH1, CTF8, RPN10, URM1, APQ12, SEC28, SDS3, ICE2, IST3, ELM1, HSL1, RAD27, LST4, DOA1, VPS51, UTH1, NAP1, DYN1, NUP133, MLP1, HAC1, BST1, BUD27, DEG1, FAR7, UBP6, PTC1, RPN4, BRE1, VAM6, RPL13A, ASM4, GET3, CYK3, ARF1, RAD57, PAA1, VPS41, RRP8, ARX1, GSG1, INO2, ARO1, NUM1, ENT5, RPA14, NUP42, RAV2, UME6, RAD9, HTA1, CHL4, PMP3, RTT103, SSD1, IPK1, MCM21, SWR1, MSN5, ESC2, XRS2, EFT2, MUS81, SPT3, ERD1, PPM1, VPS72, EMI1, COG7, GET1, CWH41, RIM8, ERV14, SGF73, MAD1, PMR1, HUR1, KEM1, HOS2, NCS6, VAM7, KIP3, RTF1, RTG2, UPF3, SLX9, PHB1, PRE9, CHO2, KRE11, QCR9, UBR1, ELP2, SER2, SMI1, YTA7, SYS1, MAD3, MAD2, YJL045W, LAS21, SRS2, BCK1, CHS6, ASF1, LSM1, PBS2, RPA34, VPS35, SET2, MNN11, CPR7, POL32, OPI3, HOC1, MCM22, HOM6, HIR3, ENT4, VPS13, BRE2, POM34, UBR2, RAD5, COX12, ARP6, CSF1, HOG1, AVL9, MMR1, UPS1, YKE2, YPT6, SEC72, MMS22, CHS5, MID2, FKS1, IKI3, VAC14, VIP1, CDC73, SST2, ERG6, RAD52, SRC1, COG8, VPS9, NUP188, TUB3, MSC1, MVP1, MSS1, CSM3, BUB2, RIM9, CTF18, POM152, SGS1, CIK1, SCJ1, MRE11, SAP30, SCS7, ZDS1, AEP2, JNM1, DYN3, GAS1, ELP6, COG6, COG5, PHO23, FAR11, EAF7, VPS27, CSE2, SSK2, BRE5, SIN3, TOP1, TLG2, PSH1, IRA2, INO4, RTS1, HST3, BUB3, STI1, DFG16, SHE4, CKB2, WHI2, ASE1, ALG8, VAM10, DIA2, WHI5, OST3, VAM3, LEO1, RGA1, VPS17, SFL1, ELG1, SLK19, RUD3, PNT1, PAC1, RIM20, HSD1, CIN1, HAP5, PDE2, CHL1, IRC15, ARL3, LGE1, ELP3, MGR2, ELP4, COX10, NIP100, CTI6, DDC1, LEA1, NEW1, ALG5, CIN2, VIK1, RLF2, EAF3, MED1, CLB2, KAR3, HDA3, YPL183W-A, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0009987; 
GO:0007049; cell cycle; 70 of 300 (23%); 126 of 1139 (11.1%); 6.668e-11; MMS4, DCC1, BIK1, HCM1, PAT1, CSM1, GET2, SWI4, ARP1, CTF8, ELM1, HSL1, UTH1, NAP1, DYN1, FAR7, RPN4, ASM4, CYK3, RAD57, GSG1, UME6, RAD9, CHL4, SSD1, MCM21, XRS2, MUS81, EMI1, RIM8, MAD1, KEM1, KIP3, MAD3, MAD2, MCM22, HIR3, MMR1, MMS22, RAD52, SRC1, TUB3, MSC1, CSM3, BUB2, CTF18, SGS1, CIK1, MRE11, FAR11, CSE2, SIN3, TOP1, RTS1, BUB3, CKB2, WHI2, ASE1, DIA2, WHI5, ELG1, SLK19, PAC1, CHL1, IRC15, NIP100, DDC1, VIK1, CLB2, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0007049; 
GO:0000723; telomere maintenance; 45 of 300 (15%); 71 of 1139 (6.2%); 7.080e-09; DEP1, GPB2, NUP60, SWD1, DCC1, MRC1, HCM1, CSM1, SRB2, THP2, CTF8, RAD27, PTC1, RPN4, BRE1, VAM6, ARF1, RAD57, RRP8, RPA14, XRS2, HUR1, KEM1, VAM7, RTF1, UPF3, CHO2, SMI1, YTA7, POL32, BRE2, RAD5, CDC73, RAD52, VPS9, SGS1, MRE11, SAP30, SIN3, WHI2, LEO1, ELG1, LEA1, MED1, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0000723; 
GO:0051641; cellular localization; 78 of 300 (26%); 158 of 1139 (13.9%); 8.849e-09; VPS8, ECM1, NUP60, SFT2, CCZ1, ARL1, SEC66, APM3, GET2, VPS29, GGA2, ARP1, CHS7, THP2, APQ12, SEC28, IST3, LST4, VPS51, DYN1, NUP133, MLP1, BST1, PTC1, ASM4, GET3, ARF1, VPS41, GSG1, NUM1, ENT5, NUP42, MSN5, ERD1, COG7, GET1, ERV14, MAD1, VAM7, KIP3, PHB1, KRE11, SYS1, CHS6, PBS2, VPS35, VPS13, POM34, AVL9, MMR1, UPS1, YPT6, SEC72, CHS5, COG8, VPS9, NUP188, TUB3, MVP1, POM152, CIK1, ZDS1, JNM1, DYN3, COG6, COG5, VPS27, TOP1, TLG2, VAM3, VPS17, RUD3, PNT1, PAC1, ARL3, NIP100, KAR3, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0051641; 
GO:0032200; telomere organization and biogenesis; 45 of 300 (15%); 72 of 1139 (6.3%); 1.449e-08; DEP1, GPB2, NUP60, SWD1, DCC1, MRC1, HCM1, CSM1, SRB2, THP2, CTF8, RAD27, PTC1, RPN4, BRE1, VAM6, ARF1, RAD57, RRP8, RPA14, XRS2, HUR1, KEM1, VAM7, RTF1, UPF3, CHO2, SMI1, YTA7, POL32, BRE2, RAD5, CDC73, RAD52, VPS9, SGS1, MRE11, SAP30, SIN3, WHI2, LEO1, ELG1, LEA1, MED1, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0032200; 
GO:0022402; cell cycle process; 58 of 300 (19%); 106 of 1139 (9.3%); 3.380e-08; MMS4, DCC1, BIK1, HCM1, CSM1, GET2, SWI4, ARP1, CTF8, HSL1, NAP1, DYN1, FAR7, RPN4, ASM4, RAD57, GSG1, UME6, CHL4, SSD1, MCM21, XRS2, MUS81, EMI1, RIM8, MAD1, KEM1, KIP3, MAD3, MAD2, MCM22, HIR3, MMS22, RAD52, SRC1, TUB3, MSC1, CSM3, BUB2, CTF18, SGS1, CIK1, MRE11, FAR11, CSE2, TOP1, RTS1, CKB2, ASE1, WHI5, SLK19, CHL1, IRC15, NIP100, DDC1, VIK1, CLB2, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0022402; 
GO:0051649; establishment of cellular localization; 73 of 300 (24%); 149 of 1139 (13.1%); 8.046e-08; VPS8, ECM1, NUP60, SFT2, CCZ1, ARL1, SEC66, APM3, GET2, VPS29, GGA2, ARP1, CHS7, THP2, APQ12, SEC28, IST3, LST4, VPS51, DYN1, NUP133, MLP1, BST1, ASM4, GET3, ARF1, VPS41, GSG1, NUM1, ENT5, NUP42, MSN5, COG7, GET1, ERV14, MAD1, VAM7, KIP3, KRE11, SYS1, CHS6, PBS2, VPS35, VPS13, POM34, AVL9, UPS1, YPT6, SEC72, CHS5, COG8, VPS9, NUP188, TUB3, MVP1, POM152, CIK1, ZDS1, JNM1, DYN3, COG6, COG5, VPS27, TOP1, TLG2, VAM3, VPS17, RUD3, PAC1, ARL3, NIP100, KAR3, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0051649; 
GO:0022403; cell cycle phase; 53 of 300 (18%); 96 of 1139 (8.4%); 1.726e-07; MMS4, DCC1, BIK1, HCM1, CSM1, GET2, SWI4, CTF8, HSL1, NAP1, DYN1, RPN4, ASM4, RAD57, GSG1, UME6, CHL4, SSD1, MCM21, XRS2, MUS81, EMI1, RIM8, MAD1, KEM1, MAD3, MAD2, MCM22, HIR3, MMS22, RAD52, SRC1, TUB3, MSC1, CSM3, BUB2, CTF18, SGS1, CIK1, MRE11, CSE2, TOP1, RTS1, CKB2, ASE1, WHI5, SLK19, CHL1, IRC15, DDC1, VIK1, CLB2, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0022403; 
GO:0000279; M phase; 45 of 300 (15%); 76 of 1139 (6.7%); 2.048e-07; MMS4, DCC1, BIK1, CSM1, GET2, CTF8, NAP1, DYN1, ASM4, RAD57, GSG1, UME6, CHL4, SSD1, MCM21, XRS2, MUS81, EMI1, RIM8, MAD1, MAD3, MAD2, MCM22, MMS22, RAD52, SRC1, TUB3, MSC1, CSM3, BUB2, CTF18, SGS1, CIK1, MRE11, CSE2, TOP1, RTS1, ASE1, SLK19, CHL1, IRC15, DDC1, VIK1, CLB2, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0000279; 
GO:0000087; M phase of mitotic cell cycle; 29 of 300 (10%); 40 of 1139 (3.5%); 3.783e-07; DCC1, BIK1, CTF8, NAP1, DYN1, ASM4, UME6, CHL4, SSD1, MCM21, MAD1, MAD3, MAD2, MCM22, SRC1, TUB3, CSM3, BUB2, CTF18, SGS1, CIK1, CSE2, TOP1, ASE1, SLK19, CHL1, VIK1, CLB2, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0000087; 
GO:0046907; intracellular transport; 67 of 300 (22%); 137 of 1139 (12.0%); 6.496e-07; VPS8, ECM1, NUP60, SFT2, CCZ1, ARL1, SEC66, APM3, GET2, VPS29, GGA2, CHS7, THP2, APQ12, SEC28, IST3, LST4, VPS51, DYN1, NUP133, MLP1, BST1, ASM4, GET3, ARF1, VPS41, GSG1, NUM1, ENT5, NUP42, MSN5, COG7, GET1, ERV14, MAD1, VAM7, KIP3, KRE11, SYS1, CHS6, PBS2, VPS35, VPS13, POM34, AVL9, UPS1, YPT6, SEC72, CHS5, COG8, VPS9, NUP188, TUB3, MVP1, POM152, ZDS1, DYN3, COG6, COG5, VPS27, TLG2, VAM3, VPS17, RUD3, PAC1, ARL3, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0046907; 
GO:0007067; mitosis; 28 of 300 (9%); 39 of 1139 (3.4%); 1.115e-06; DCC1, BIK1, CTF8, DYN1, ASM4, UME6, CHL4, SSD1, MCM21, MAD1, MAD3, MAD2, MCM22, SRC1, TUB3, CSM3, BUB2, CTF18, SGS1, CIK1, CSE2, TOP1, ASE1, SLK19, CHL1, VIK1, CLB2, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0007067; 
GO:0007059; chromosome segregation; 23 of 300 (8%); 29 of 1139 (2.5%); 1.321e-06; DCC1, PAT1, CSM1, CTF8, DYN1, CHL4, MCM21, MCM22, MMS22, SRC1, TUB3, CSM3, CTF18, SGS1, CIK1, CSE2, TOP1, RTS1, SLK19, CHL1, IRC15, VIK1, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0007059; 
GO:0000278; mitotic cell cycle; 40 of 300 (13%); 67 of 1139 (5.9%); 1.603e-06; DCC1, BIK1, HCM1, SWI4, ARP1, CTF8, HSL1, NAP1, DYN1, RPN4, ASM4, UME6, CHL4, SSD1, MCM21, MAD1, KEM1, KIP3, MAD3, MAD2, MCM22, HIR3, SRC1, TUB3, CSM3, BUB2, CTF18, SGS1, CIK1, CSE2, TOP1, CKB2, ASE1, WHI5, SLK19, CHL1, NIP100, VIK1, CLB2, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0000278; 
GO:0006325; establishment and/or maintenance of chromatin architecture; 45 of 300 (15%); 81 of 1139 (7.1%); 3.683e-06; SWC3, DEP1, SWD1, HIR1, HHF1, DPB3, MRC1, SNT1, SCS2, SDS3, UTH1, NAP1, BRE1, PAA1, UME6, HTA1, SWR1, ESC2, SPT3, VPS72, SGF73, HOS2, RTF1, RTG2, ASF1, SET2, HIR3, BRE2, ARP6, CDC73, SAP30, ZDS1, PHO23, EAF7, SIN3, TOP1, HST3, LEO1, LGE1, ELP3, CTI6, NEW1, RLF2, EAF3, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0006325; 
GO:0016192; vesicle-mediated transport; 48 of 300 (16%); 91 of 1139 (8.0%); 1.081e-05; VPS8, SLA1, EDE1, SFT2, CCZ1, ARL1, APM3, THR4, GET2, VPS29, GGA2, CHS7, SEC28, LST4, VPS51, BST1, GET3, ARF1, VPS41, GSG1, ENT5, COG7, GET1, ERV14, VAM7, KRE11, SYS1, CHS6, VPS35, ENT4, VPS13, AVL9, YPT6, CHS5, FKS1, COG8, COG6, COG5, VPS27, TLG2, WHI2, GYP1, VAM3, VPS17, RUD3, HSD1, ARL3, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0016192; 
GO:0033036; macromolecule localization; 61 of 300 (20%); 128 of 1139 (11.2%); 1.616e-05; VPS8, NUP60, SFT2, CCZ1, ARL1, SEC66, MCX1, APM3, VPS29, GGA2, CHS7, THP2, APQ12, SEC28, IST3, LST4, VPS51, NUP133, MLP1, BST1, VAM6, ASM4, ARF1, VPS41, ENT5, NUP42, RAV2, MSN5, ERD1, COG7, ELP2, SYS1, CHS6, PBS2, VPS35, VPS13, POM34, UPS1, YPT6, SEC72, CHS5, IKI3, VAC14, COG8, VPS9, NUP188, MVP1, POM152, SCJ1, ZDS1, COG6, COG5, VPS27, TLG2, SHE4, VAM3, VPS17, PNT1, ARL3, ELP3, NEW1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0033036; 
GO:0043283; biopolymer metabolic process; 147 of 300 (49%); 410 of 1139 (36.0%); 2.686e-05; SWC3, DEP1, CNE1, SWD1, HIR1, SKT5, UBC4, MMS4, DPB3, DCC1, MRC1, SNT1, HCM1, PAT1, CSM1, SWI4, UBP3, SLT2, RRM3, SRB2, GGA2, UBA4, CHS7, RTT107, THP2, CTF8, RPN10, URM1, SDS3, IST3, ELM1, HSL1, RAD27, DOA1, MLP1, HAC1, BST1, DEG1, UBP6, PTC1, RPN4, BRE1, RAD57, VPS41, RRP8, INO2, RPA14, UME6, RAD9, HTA1, RTT103, SWR1, ESC2, XRS2, EFT2, MUS81, SPT3, ERD1, PPM1, CWH41, RIM8, SGF73, PMR1, HUR1, KEM1, HOS2, NCS6, RTF1, UPF3, SLX9, PRE9, UBR1, ELP2, SMI1, YTA7, LAS21, SRS2, BCK1, CHS6, ASF1, LSM1, PBS2, RPA34, SET2, MNN11, POL32, HOC1, HIR3, VPS13, BRE2, UBR2, RAD5, ARP6, HOG1, UPS1, MMS22, CHS5, FKS1, IKI3, CDC73, RAD52, VPS9, MSC1, MSS1, CSM3, CTF18, SGS1, SCJ1, MRE11, SAP30, ELP6, PHO23, EAF7, CSE2, SSK2, BRE5, SIN3, TOP1, PSH1, INO4, RTS1, HST3, DFG16, SHE4, CKB2, ALG8, DIA2, WHI5, OST3, LEO1, SFL1, ELG1, RIM20, HAP5, CHL1, IRC15, LGE1, ELP3, ELP4, CTI6, DDC1, LEA1, ALG5, EAF3, MED1, HDA3, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0043283; 
GO:0016569; covalent chromatin modification; 24 of 300 (8%); 34 of 1139 (3.0%); 3.053e-05; DEP1, SWD1, SNT1, SDS3, BRE1, UME6, SPT3, SGF73, HOS2, RTF1, ASF1, SET2, BRE2, CDC73, SAP30, PHO23, EAF7, SIN3, HST3, LEO1, LGE1, CTI6, EAF3, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0016569; 
GO:0016570; histone modification; 24 of 300 (8%); 34 of 1139 (3.0%); 3.053e-05; DEP1, SWD1, SNT1, SDS3, BRE1, UME6, SPT3, SGF73, HOS2, RTF1, ASF1, SET2, BRE2, CDC73, SAP30, PHO23, EAF7, SIN3, HST3, LEO1, LGE1, CTI6, EAF3, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0016570; 
GO:0048193; Golgi vesicle transport; 28 of 300 (9%); 43 of 1139 (3.8%); 3.403e-05; SFT2, ARL1, APM3, GET2, GGA2, CHS7, SEC28, LST4, BST1, GET3, ARF1, GSG1, ENT5, COG7, GET1, ERV14, VAM7, KRE11, SYS1, CHS6, AVL9, CHS5, COG8, COG6, COG5, VAM3, RUD3, ARL3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0048193; 
GO:0019219; regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process; 74 of 300 (25%); 169 of 1139 (14.8%); 3.933e-05; SWC3, DEP1, GPB2, SWD1, HIR1, DPB3, MRC1, HCM1, SWI4, SCS2, SRB2, RTT107, THP2, SDS3, UTH1, MLP1, HAC1, BUD27, RPN4, BRE1, INO2, UME6, RAD9, HTA1, RTT103, IPK1, SWR1, ESC2, SPT3, VPS72, EMI1, SGF73, HOS2, RTF1, ELP2, SMI1, ASF1, PBS2, SET2, HIR3, BRE2, ARP6, HOG1, MMS22, IKI3, CDC73, CSM3, MRE11, SAP30, ZDS1, ELP6, PHO23, EAF7, CSE2, SSK2, SIN3, TOP1, IRA2, INO4, HST3, CKB2, WHI5, LEO1, SFL1, ELG1, HAP5, LGE1, ELP3, ELP4, CTI6, RLF2, EAF3, MED1, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0019219; 
GO:0016568; chromatin modification; 39 of 300 (13%); 70 of 1139 (6.1%); 3.943e-05; SWC3, DEP1, SWD1, HIR1, DPB3, MRC1, SNT1, SCS2, SDS3, UTH1, BRE1, UME6, SWR1, ESC2, SPT3, VPS72, SGF73, HOS2, RTF1, RTG2, ASF1, SET2, BRE2, ARP6, CDC73, SAP30, ZDS1, PHO23, EAF7, SIN3, TOP1, HST3, LEO1, LGE1, ELP3, CTI6, RLF2, EAF3, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0016568; 
GO:0015031; protein transport; 55 of 300 (18%); 114 of 1139 (10.0%); 5.358e-05; VPS8, NUP60, SFT2, CCZ1, ARL1, SEC66, MCX1, APM3, VPS29, GGA2, CHS7, SEC28, LST4, VPS51, NUP133, MLP1, BST1, VAM6, ASM4, ARF1, VPS41, ENT5, NUP42, RAV2, MSN5, ERD1, COG7, ELP2, SYS1, CHS6, PBS2, VPS35, VPS13, POM34, UPS1, YPT6, SEC72, CHS5, IKI3, VAC14, COG8, VPS9, NUP188, MVP1, POM152, SCJ1, COG6, COG5, VPS27, TLG2, VAM3, VPS17, PNT1, ARL3, ELP3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0015031; 
GO:0045184; establishment of protein localization; 55 of 300 (18%); 114 of 1139 (10.0%); 5.358e-05; VPS8, NUP60, SFT2, CCZ1, ARL1, SEC66, MCX1, APM3, VPS29, GGA2, CHS7, SEC28, LST4, VPS51, NUP133, MLP1, BST1, VAM6, ASM4, ARF1, VPS41, ENT5, NUP42, RAV2, MSN5, ERD1, COG7, ELP2, SYS1, CHS6, PBS2, VPS35, VPS13, POM34, UPS1, YPT6, SEC72, CHS5, IKI3, VAC14, COG8, VPS9, NUP188, MVP1, POM152, SCJ1, COG6, COG5, VPS27, TLG2, VAM3, VPS17, PNT1, ARL3, ELP3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0045184; 
GO:0051052; regulation of DNA metabolic process; 22 of 300 (7%); 31 of 1139 (2.7%); 9.936e-05; MRC1, RTT107, BUD27, RPN4, BRE1, RAD9, RTT103, IPK1, RTF1, ASF1, PBS2, MMS22, CDC73, CSM3, CSE2, SSK2, SIN3, TOP1, CKB2, LEO1, ELG1, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0051052; 
GO:0008104; protein localization; 55 of 300 (18%); 116 of 1139 (10.2%); 1.150e-04; VPS8, NUP60, SFT2, CCZ1, ARL1, SEC66, MCX1, APM3, VPS29, GGA2, CHS7, SEC28, LST4, VPS51, NUP133, MLP1, BST1, VAM6, ASM4, ARF1, VPS41, ENT5, NUP42, RAV2, MSN5, ERD1, COG7, ELP2, SYS1, CHS6, PBS2, VPS35, VPS13, POM34, UPS1, YPT6, SEC72, CHS5, IKI3, VAC14, COG8, VPS9, NUP188, MVP1, POM152, SCJ1, COG6, COG5, VPS27, TLG2, VAM3, VPS17, PNT1, ARL3, ELP3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0008104; 
GO:0050789; regulation of biological process; 104 of 300 (35%); 269 of 1139 (23.6%); 1.310e-04; SWC3, DEP1, GPB2, SWD1, HIR1, UBC4, DPB3, MRC1, SNT1, HCM1, PAT1, SWI4, SCS2, BEM2, SRB2, RTT107, THP2, SDS3, ELM1, HSL1, UTH1, MLP1, HAC1, BST1, BUD27, RPN4, BRE1, INO2, RAV2, UME6, RAD9, HTA1, RTT103, IPK1, SWR1, ESC2, SPT3, ERD1, VPS72, EMI1, SGF73, MAD1, KEM1, HOS2, GCN1, RTF1, UPF3, PHB1, ELP2, SMI1, MAD3, MAD2, ASF1, PBS2, VPS35, SET2, HIR3, VPS13, BRE2, ARP6, HOG1, MMS22, FKS1, IKI3, CDC73, SST2, CSM3, BUB2, MRE11, SAP30, ZDS1, ELP6, PHO23, EAF7, VPS27, CSE2, SSK2, SIN3, TOP1, IRA2, INO4, HST3, BUB3, CKB2, WHI2, ASE1, GYP1, WHI5, LEO1, RGA1, SFL1, ELG1, HAP5, LGE1, ELP3, ELP4, CTI6, DDC1, RLF2, EAF3, MED1, CLB2, HDA3, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0050789; 
GO:0043284; biopolymer biosynthetic process; 57 of 300 (19%); 123 of 1139 (10.8%); 1.800e-04; SWC3, DEP1, HIR1, SKT5, HCM1, SWI4, SRB2, CHS7, THP2, SDS3, HAC1, RPN4, INO2, RPA14, UME6, RTT103, SWR1, ESC2, EFT2, SPT3, SGF73, HOS2, RTF1, ELP2, SMI1, CHS6, ASF1, RPA34, SET2, HIR3, BRE2, ARP6, HOG1, FKS1, IKI3, CDC73, SAP30, ELP6, PHO23, EAF7, CSE2, SIN3, TOP1, PSH1, INO4, HST3, WHI5, LEO1, SFL1, HAP5, LGE1, ELP3, ELP4, CTI6, EAF3, MED1, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0043284; 
GO:0006350; transcription; 52 of 300 (17%); 110 of 1139 (9.7%); 3.013e-04; SWC3, DEP1, HIR1, HCM1, SWI4, SRB2, THP2, SDS3, HAC1, RPN4, INO2, RPA14, UME6, RTT103, SWR1, ESC2, SPT3, SGF73, HOS2, RTF1, ELP2, SMI1, ASF1, RPA34, SET2, HIR3, BRE2, ARP6, HOG1, IKI3, CDC73, SAP30, ELP6, PHO23, EAF7, CSE2, SIN3, TOP1, PSH1, INO4, HST3, WHI5, LEO1, SFL1, HAP5, LGE1, ELP3, ELP4, CTI6, EAF3, MED1, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0006350; 
GO:0051053; negative regulation of DNA metabolic process; 20 of 300 (7%); 28 of 1139 (2.5%); 3.217e-04; MRC1, RTT107, BUD27, BRE1, RAD9, RTT103, IPK1, RTF1, ASF1, PBS2, MMS22, CDC73, CSM3, CSE2, SSK2, SIN3, CKB2, LEO1, ELG1, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0051053; 
GO:0000819; sister chromatid segregation; 16 of 300 (5%); 20 of 1139 (1.8%); 3.711e-04; DCC1, CTF8, DYN1, MMS22, SRC1, TUB3, CSM3, CTF18, SGS1, CIK1, CSE2, TOP1, CHL1, IRC15, VIK1, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0000819; 
GO:0051301; cell division; 32 of 300 (11%); 57 of 1139 (5.0%); 5.409e-04; SLA1, SKT5, BIK1, PAT1, BEM2, UBA4, URM1, ELM1, VPS51, UTH1, NAP1, BUD27, ASM4, CYK3, CHL4, SSD1, MCM21, ERV14, MAD1, MAD3, MAD2, MCM22, MMR1, CHS5, BUB2, SIN3, ASE1, RGA1, SLK19, PAC1, CLB2, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0051301; 
GO:0045449; regulation of transcription; 65 of 300 (22%); 151 of 1139 (13.3%); 6.967e-04; SWC3, DEP1, GPB2, SWD1, HIR1, DPB3, MRC1, HCM1, SWI4, SCS2, SRB2, THP2, SDS3, UTH1, MLP1, HAC1, RPN4, BRE1, INO2, UME6, RAD9, HTA1, RTT103, SWR1, ESC2, SPT3, VPS72, EMI1, SGF73, HOS2, RTF1, ELP2, SMI1, ASF1, SET2, HIR3, BRE2, ARP6, HOG1, IKI3, CDC73, MRE11, SAP30, ZDS1, ELP6, PHO23, EAF7, CSE2, SIN3, TOP1, INO4, HST3, CKB2, WHI5, LEO1, SFL1, HAP5, LGE1, ELP3, ELP4, CTI6, RLF2, EAF3, MED1, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0045449; 
GO:0006355; regulation of transcription, DNA-dependent; 63 of 300 (21%); 145 of 1139 (12.7%); 7.120e-04; SWC3, DEP1, GPB2, SWD1, HIR1, DPB3, MRC1, HCM1, SWI4, SCS2, SRB2, THP2, SDS3, UTH1, HAC1, RPN4, BRE1, INO2, UME6, RAD9, HTA1, RTT103, SWR1, ESC2, SPT3, EMI1, SGF73, HOS2, RTF1, ELP2, SMI1, ASF1, SET2, HIR3, BRE2, ARP6, HOG1, IKI3, CDC73, MRE11, SAP30, ZDS1, ELP6, PHO23, EAF7, CSE2, SIN3, TOP1, INO4, HST3, CKB2, WHI5, LEO1, SFL1, HAP5, LGE1, ELP3, ELP4, CTI6, RLF2, EAF3, MED1, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0006355; 
GO:0051252; regulation of RNA metabolic process; 63 of 300 (21%); 146 of 1139 (12.8%); 9.620e-04; SWC3, DEP1, GPB2, SWD1, HIR1, DPB3, MRC1, HCM1, SWI4, SCS2, SRB2, THP2, SDS3, UTH1, HAC1, RPN4, BRE1, INO2, UME6, RAD9, HTA1, RTT103, SWR1, ESC2, SPT3, EMI1, SGF73, HOS2, RTF1, ELP2, SMI1, ASF1, SET2, HIR3, BRE2, ARP6, HOG1, IKI3, CDC73, MRE11, SAP30, ZDS1, ELP6, PHO23, EAF7, CSE2, SIN3, TOP1, INO4, HST3, CKB2, WHI5, LEO1, SFL1, HAP5, LGE1, ELP3, ELP4, CTI6, RLF2, EAF3, MED1, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0051252; 
GO:0065007; biological regulation; 114 of 300 (38%); 312 of 1139 (27.4%); 1.014e-03; SWC3, DEP1, GPB2, SWD1, HIR1, UBC4, DPB3, MRC1, SNT1, HCM1, PAT1, SWI4, SCS2, BEM2, SLT2, SRB2, UBA4, RTT107, THP2, SDS3, ELM1, HSL1, VPS51, UTH1, MLP1, HAC1, BST1, BUD27, PTC1, RPN4, BRE1, INO2, RPA14, NBP2, RAV2, UME6, RAD9, HTA1, PMP3, RTT103, IPK1, SWR1, ESC2, SPT3, ERD1, VPS72, EMI1, GET1, SGF73, MAD1, KEM1, HOS2, GCN1, RTF1, UPF3, PHB1, ELP2, SMI1, MAD3, MAD2, ASF1, PBS2, VPS35, SET2, HIR3, VPS13, BRE2, ARP6, HOG1, MMS22, FKS1, IKI3, CDC73, SST2, CSM3, BUB2, MRE11, SAP30, ZDS1, ELP6, PHO23, EAF7, VPS27, CSE2, SSK2, SIN3, TOP1, IRA2, INO4, HST3, BUB3, DFG16, CKB2, WHI2, ASE1, GYP1, WHI5, LEO1, RGA1, SFL1, ELG1, HAP5, IRC15, LGE1, ELP3, ELP4, CTI6, DDC1, RLF2, EAF3, MED1, CLB2, HDA3, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0065007; 
GO:0000018; regulation of DNA recombination; 18 of 300 (6%); 25 of 1139 (2.2%); 1.036e-03; RTT107, BUD27, BRE1, RTT103, IPK1, RTF1, ASF1, PBS2, MMS22, CDC73, CSE2, SSK2, SIN3, TOP1, CKB2, LEO1, ELG1, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0000018; 
GO:0000070; mitotic sister chromatid segregation; 14 of 300 (5%); 17 of 1139 (1.5%); 1.063e-03; DCC1, CTF8, DYN1, SRC1, TUB3, CSM3, CTF18, SGS1, CIK1, CSE2, TOP1, CHL1, VIK1, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0000070; 
GO:0010525; regulation of transposition, RNA-mediated; 17 of 300 (6%); 23 of 1139 (2.0%); 1.134e-03; RTT107, BUD27, BRE1, RTT103, IPK1, RTF1, ASF1, PBS2, MMS22, CDC73, CSE2, SSK2, SIN3, CKB2, LEO1, ELG1, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0010525; 
GO:0010526; negative regulation of transposition, RNA-mediated; 17 of 300 (6%); 23 of 1139 (2.0%); 1.134e-03; RTT107, BUD27, BRE1, RTT103, IPK1, RTF1, ASF1, PBS2, MMS22, CDC73, CSE2, SSK2, SIN3, CKB2, LEO1, ELG1, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0010526; 
GO:0010528; regulation of transposition; 17 of 300 (6%); 23 of 1139 (2.0%); 1.134e-03; RTT107, BUD27, BRE1, RTT103, IPK1, RTF1, ASF1, PBS2, MMS22, CDC73, CSE2, SSK2, SIN3, CKB2, LEO1, ELG1, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0010528; 
GO:0010529; negative regulation of transposition; 17 of 300 (6%); 23 of 1139 (2.0%); 1.134e-03; RTT107, BUD27, BRE1, RTT103, IPK1, RTF1, ASF1, PBS2, MMS22, CDC73, CSE2, SSK2, SIN3, CKB2, LEO1, ELG1, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0010529; 
GO:0019222; regulation of metabolic process; 81 of 300 (27%); 204 of 1139 (17.9%); 1.503e-03; SWC3, DEP1, GPB2, SWD1, HIR1, UBC4, DPB3, MRC1, HCM1, PAT1, SWI4, SCS2, SRB2, RTT107, THP2, SDS3, UTH1, MLP1, HAC1, BUD27, RPN4, BRE1, INO2, RAV2, UME6, RAD9, HTA1, RTT103, IPK1, SWR1, ESC2, SPT3, VPS72, EMI1, SGF73, HOS2, GCN1, RTF1, UPF3, PHB1, ELP2, SMI1, ASF1, PBS2, SET2, HIR3, BRE2, ARP6, HOG1, MMS22, IKI3, CDC73, CSM3, MRE11, SAP30, ZDS1, ELP6, PHO23, EAF7, CSE2, SSK2, SIN3, TOP1, IRA2, INO4, HST3, CKB2, ASE1, WHI5, LEO1, SFL1, ELG1, HAP5, LGE1, ELP3, ELP4, CTI6, RLF2, EAF3, MED1, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0019222; 
GO:0050794; regulation of cellular process; 96 of 300 (32%); 254 of 1139 (22.3%); 1.850e-03; SWC3, DEP1, GPB2, SWD1, HIR1, DPB3, MRC1, SNT1, HCM1, PAT1, SWI4, SCS2, BEM2, SRB2, RTT107, THP2, SDS3, ELM1, HSL1, UTH1, MLP1, HAC1, BUD27, RPN4, BRE1, INO2, RAV2, UME6, RAD9, HTA1, RTT103, IPK1, SWR1, ESC2, SPT3, VPS72, EMI1, SGF73, MAD1, KEM1, HOS2, GCN1, RTF1, UPF3, PHB1, ELP2, SMI1, MAD3, MAD2, ASF1, PBS2, SET2, HIR3, BRE2, ARP6, HOG1, MMS22, FKS1, IKI3, CDC73, SST2, CSM3, BUB2, MRE11, SAP30, ZDS1, ELP6, PHO23, EAF7, CSE2, SSK2, SIN3, TOP1, IRA2, INO4, HST3, BUB3, CKB2, ASE1, GYP1, WHI5, LEO1, SFL1, ELG1, HAP5, LGE1, ELP3, ELP4, CTI6, DDC1, RLF2, EAF3, MED1, CLB2, HDA3, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0050794; 
GO:0045934; negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process; 36 of 300 (12%); 70 of 1139 (6.1%); 1.859e-03; SWD1, DPB3, MRC1, SCS2, RTT107, SDS3, BUD27, BRE1, UME6, RAD9, HTA1, RTT103, IPK1, ESC2, RTF1, ASF1, PBS2, BRE2, HOG1, MMS22, CDC73, CSM3, SAP30, ZDS1, CSE2, SSK2, SIN3, TOP1, IRA2, HST3, CKB2, LEO1, SFL1, ELG1, RLF2, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0045934; 
GO:0031323; regulation of cellular metabolic process; 79 of 300 (26%); 199 of 1139 (17.5%); 2.130e-03; SWC3, DEP1, GPB2, SWD1, HIR1, DPB3, MRC1, HCM1, PAT1, SWI4, SCS2, SRB2, RTT107, THP2, SDS3, UTH1, MLP1, HAC1, BUD27, RPN4, BRE1, INO2, UME6, RAD9, HTA1, RTT103, IPK1, SWR1, ESC2, SPT3, VPS72, EMI1, SGF73, HOS2, GCN1, RTF1, UPF3, PHB1, ELP2, SMI1, ASF1, PBS2, SET2, HIR3, BRE2, ARP6, HOG1, MMS22, IKI3, CDC73, CSM3, MRE11, SAP30, ZDS1, ELP6, PHO23, EAF7, CSE2, SSK2, SIN3, TOP1, IRA2, INO4, HST3, CKB2, ASE1, WHI5, LEO1, SFL1, ELG1, HAP5, LGE1, ELP3, ELP4, CTI6, RLF2, EAF3, MED1, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0031323; 
GO:0045910; negative regulation of DNA recombination; 17 of 300 (6%); 24 of 1139 (2.1%); 2.962e-03; RTT107, BUD27, BRE1, RTT103, IPK1, RTF1, ASF1, PBS2, MMS22, CDC73, CSE2, SSK2, SIN3, CKB2, LEO1, ELG1, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0045910; 
GO:0006259; DNA metabolic process; 42 of 300 (14%); 88 of 1139 (7.7%); 3.312e-03; MMS4, DPB3, DCC1, MRC1, CSM1, RRM3, RTT107, THP2, CTF8, RAD27, DOA1, MLP1, RAD57, UME6, RAD9, HTA1, XRS2, MUS81, HUR1, KEM1, SRS2, POL32, RAD5, MMS22, CDC73, RAD52, MSC1, CSM3, CTF18, SGS1, MRE11, EAF7, SIN3, TOP1, SHE4, DIA2, ELG1, CHL1, IRC15, LGE1, DDC1, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0006259; 
GO:0010468; regulation of gene expression; 68 of 300 (23%); 166 of 1139 (14.6%); 3.440e-03; SWC3, DEP1, GPB2, SWD1, HIR1, DPB3, MRC1, HCM1, PAT1, SWI4, SCS2, SRB2, THP2, SDS3, UTH1, MLP1, HAC1, RPN4, BRE1, INO2, UME6, RAD9, HTA1, RTT103, SWR1, ESC2, SPT3, VPS72, EMI1, SGF73, HOS2, GCN1, RTF1, UPF3, ELP2, SMI1, ASF1, SET2, HIR3, BRE2, ARP6, HOG1, IKI3, CDC73, MRE11, SAP30, ZDS1, ELP6, PHO23, EAF7, CSE2, SIN3, TOP1, INO4, HST3, CKB2, WHI5, LEO1, SFL1, HAP5, LGE1, ELP3, ELP4, CTI6, RLF2, EAF3, MED1, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0010468; 
GO:0043170; macromolecule metabolic process; 170 of 300 (57%); 525 of 1139 (46.1%); 7.286e-03; SWC3, DEP1, CNE1, NUP60, SWD1, HIR1, SKT5, HHF1, UBC4, MMS4, DPB3, APM3, DCC1, MRC1, SNT1, HCM1, PAT1, CSM1, SWI4, UBP3, RPL8A, SLT2, RRM3, SRB2, GGA2, UBA4, CHS7, RTT107, THP2, PTH1, CTF8, RPN10, URM1, SEC28, SDS3, IST3, ELM1, HSL1, RAD27, DOA1, NAP1, MLP1, HAC1, BST1, BUD27, DEG1, UBP6, PTC1, RPN4, BRE1, RPL13A, ASM4, RAD57, VPS41, RRP8, ARX1, INO2, RPA14, UME6, RAD9, HTA1, RTT103, SWR1, ESC2, XRS2, EFT2, MUS81, SPT3, ERD1, PPM1, CWH41, RIM8, SGF73, PMR1, HUR1, KEM1, HOS2, NCS6, KIP3, RTF1, UPF3, SLX9, PHB1, PRE9, UBR1, ELP2, SMI1, YTA7, LAS21, SRS2, BCK1, CHS6, ASF1, LSM1, PBS2, RPA34, SET2, MNN11, CPR7, POL32, HOC1, HIR3, VPS13, BRE2, UBR2, RAD5, COX12, ARP6, HOG1, UPS1, YKE2, MMS22, CHS5, FKS1, IKI3, CDC73, RAD52, VPS9, TUB3, MSC1, MSS1, CSM3, CTF18, SGS1, SCJ1, MRE11, SAP30, AEP2, ELP6, PHO23, EAF7, CSE2, SSK2, BRE5, SIN3, TOP1, PSH1, INO4, RTS1, HST3, STI1, DFG16, SHE4, CKB2, ALG8, DIA2, WHI5, OST3, LEO1, SFL1, ELG1, RIM20, CIN1, HAP5, CHL1, IRC15, LGE1, ELP3, ELP4, CTI6, DDC1, LEA1, ALG5, CIN2, RLF2, EAF3, MED1, HDA3, YPL183W-A, SEM1; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0043170; 
GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid metabolic process; 97 of 300 (32%); 265 of 1139 (23.3%); 9.080e-03; SWC3, DEP1, HIR1, MMS4, DPB3, DCC1, MRC1, HCM1, PAT1, CSM1, SWI4, RRM3, SRB2, RTT107, THP2, CTF8, SDS3, IST3, RAD27, DOA1, MLP1, HAC1, DEG1, PTC1, RPN4, RAD57, RRP8, INO2, RPA14, UME6, RAD9, HTA1, RTT103, SWR1, ESC2, XRS2, MUS81, SPT3, SGF73, HUR1, KEM1, HOS2, NCS6, RTF1, UPF3, SLX9, ELP2, SMI1, SRS2, ASF1, LSM1, RPA34, SET2, POL32, HIR3, BRE2, RAD5, ARP6, HOG1, MMS22, IKI3, CDC73, RAD52, MSC1, MSS1, CSM3, CTF18, SGS1, MRE11, SAP30, ELP6, PHO23, EAF7, CSE2, SIN3, TOP1, PSH1, INO4, HST3, SHE4, DIA2, WHI5, LEO1, SFL1, ELG1, HAP5, CHL1, IRC15, LGE1, ELP3, ELP4, CTI6, DDC1, LEA1, EAF3, MED1, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0006139; 
GO:0016575; histone deacetylation; 12 of 300 (4%); 15 of 1139 (1.3%); 1.099e-02; DEP1, SNT1, SDS3, UME6, HOS2, SAP30, PHO23, SIN3, HST3, CTI6, EAF3, HDA3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0016575; 
GO:0051656; establishment of organelle localization; 12 of 300 (4%); 15 of 1139 (1.3%); 1.099e-02; ECM1, ARP1, DYN1, NUM1, KIP3, TUB3, CIK1, JNM1, DYN3, TOP1, PAC1, NIP100; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0051656; 
GO:0016197; endosome transport; 13 of 300 (4%); 17 of 1139 (1.5%); 1.118e-02; VPS8, SFT2, VPS29, GGA2, SEC28, VPS51, ENT5, SYS1, VPS35, VPS13, YPT6, VPS27, VPS17; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0016197; 
GO:0007062; sister chromatid cohesion; 8 of 300 (3%); 8 of 1139 (0.7%); 1.236e-02; DCC1, CTF8, CSM3, CTF18, RTS1, CHL1, VIK1, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0007062; 
GO:0048519; negative regulation of biological process; 42 of 300 (14%); 93 of 1139 (8.2%); 1.896e-02; GPB2, SWD1, DPB3, MRC1, SNT1, SCS2, RTT107, SDS3, BUD27, BRE1, UME6, RAD9, HTA1, RTT103, IPK1, ESC2, HOS2, RTF1, PHB1, ASF1, PBS2, BRE2, HOG1, MMS22, CDC73, SST2, CSM3, SAP30, ZDS1, CSE2, SSK2, SIN3, TOP1, IRA2, HST3, CKB2, ASE1, LEO1, SFL1, ELG1, RLF2, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0048519; 
GO:0048523; negative regulation of cellular process; 42 of 300 (14%); 93 of 1139 (8.2%); 1.896e-02; GPB2, SWD1, DPB3, MRC1, SNT1, SCS2, RTT107, SDS3, BUD27, BRE1, UME6, RAD9, HTA1, RTT103, IPK1, ESC2, HOS2, RTF1, PHB1, ASF1, PBS2, BRE2, HOG1, MMS22, CDC73, SST2, CSM3, SAP30, ZDS1, CSE2, SSK2, SIN3, TOP1, IRA2, HST3, CKB2, ASE1, LEO1, SFL1, ELG1, RLF2, EAF3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0048523; 
GO:0051640; organelle localization; 16 of 300 (5%); 24 of 1139 (2.1%); 1.903e-02; ECM1, ARP1, DYN1, NUP133, PTC1, NUM1, KIP3, PHB1, MMR1, TUB3, CIK1, JNM1, DYN3, TOP1, PAC1, NIP100; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0051640; 
GO:0009059; macromolecule biosynthetic process; 73 of 300 (24%); 192 of 1139 (16.9%); 3.620e-02; SWC3, DEP1, HIR1, SKT5, HCM1, SWI4, RPL8A, SRB2, CHS7, THP2, PTH1, SDS3, HAC1, RPN4, RPL13A, INO2, RPA14, UME6, RTT103, SWR1, ESC2, EFT2, SPT3, ERD1, CWH41, SGF73, PMR1, HOS2, RTF1, ELP2, SMI1, LAS21, CHS6, ASF1, RPA34, SET2, MNN11, HOC1, HIR3, BRE2, ARP6, HOG1, FKS1, IKI3, CDC73, MSS1, SAP30, AEP2, ELP6, PHO23, EAF7, CSE2, SIN3, TOP1, PSH1, INO4, RTS1, HST3, ALG8, WHI5, OST3, LEO1, SFL1, HAP5, LGE1, ELP3, ELP4, CTI6, ALG5, EAF3, MED1, HDA3, YPL183W-A; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0009059; 
GO:0007064; mitotic sister chromatid cohesion; 7 of 300 (2%); 7 of 1139 (0.6%); 4.775e-02; DCC1, CTF8, CSM3, CTF18, CHL1, VIK1, KAR3; http://www.ebi.ac.uk/ego/DisplayGoTerm?selected=GO:0007064;